Addition of Spironolactone in Patients With Resistant Arterial Hypertension
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of spironolactone on lowering blood
pressure when added to therapy in patients with resistant arterial hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Jan Vaclavík
Collaborators:
Brno University Hospital Czech Society of Hypertension Gedeon Richter Ltd. Olomouc Military Hospital Prostejov Hospital